nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—ALOX5—hematologic cancer	0.358	1	CbGaD
Meclofenamic acid—PTGS2—Lenalidomide—hematologic cancer	0.0585	0.157	CbGbCtD
Meclofenamic acid—AKR1C3—Doxorubicin—hematologic cancer	0.0553	0.148	CbGbCtD
Meclofenamic acid—PTGS2—Thalidomide—hematologic cancer	0.0312	0.0838	CbGbCtD
Meclofenamic acid—SLCO1C1—Methotrexate—hematologic cancer	0.0307	0.0825	CbGbCtD
Meclofenamic acid—PTGS1—Bortezomib—hematologic cancer	0.0303	0.0812	CbGbCtD
Meclofenamic acid—PTGS1—Thalidomide—hematologic cancer	0.0264	0.0707	CbGbCtD
Meclofenamic acid—PTGS1—Ifosfamide—hematologic cancer	0.0232	0.0623	CbGbCtD
Meclofenamic acid—PTGS1—Imatinib—hematologic cancer	0.0222	0.0595	CbGbCtD
Meclofenamic acid—PTGS2—Triamcinolone—hematologic cancer	0.0216	0.0581	CbGbCtD
Meclofenamic acid—PTGS2—Betamethasone—hematologic cancer	0.0186	0.0498	CbGbCtD
Meclofenamic acid—PTGS2—Cisplatin—hematologic cancer	0.0134	0.0359	CbGbCtD
Meclofenamic acid—PTGS2—Etoposide—hematologic cancer	0.0131	0.0352	CbGbCtD
Meclofenamic acid—PTGS1—Etoposide—hematologic cancer	0.0111	0.0298	CbGbCtD
Meclofenamic acid—PTGS2—Dexamethasone—hematologic cancer	0.0108	0.029	CbGbCtD
Meclofenamic acid—SLC22A6—Methotrexate—hematologic cancer	0.00643	0.0172	CbGbCtD
Meclofenamic acid—PTGS2—ovarian follicle—hematologic cancer	0.00527	0.183	CbGeAlD
Meclofenamic acid—KCNQ2—gonad—hematologic cancer	0.00224	0.0777	CbGeAlD
Meclofenamic acid—KCNQ3—lung—hematologic cancer	0.00186	0.0645	CbGeAlD
Meclofenamic acid—ALOX5—hematopoietic system—hematologic cancer	0.00166	0.0576	CbGeAlD
Meclofenamic acid—KCNQ2—testis—hematologic cancer	0.00161	0.056	CbGeAlD
Meclofenamic acid—Niclosamide—STAT3—hematologic cancer	0.0013	0.285	CrCbGaD
Meclofenamic acid—AKR1C3—blood—hematologic cancer	0.00125	0.0433	CbGeAlD
Meclofenamic acid—AKR1C3—bone marrow—hematologic cancer	0.00121	0.0419	CbGeAlD
Meclofenamic acid—SLCO1C1—testis—hematologic cancer	0.00112	0.039	CbGeAlD
Meclofenamic acid—ALOX5—blood—hematologic cancer	0.0011	0.0381	CbGeAlD
Meclofenamic acid—AKR1C3—lung—hematologic cancer	0.00109	0.0379	CbGeAlD
Meclofenamic acid—ALOX5—bone marrow—hematologic cancer	0.00106	0.0369	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—HSPA5—hematologic cancer	0.00103	0.226	CrCbGaD
Meclofenamic acid—AKR1C3—testis—hematologic cancer	0.00103	0.0358	CbGeAlD
Meclofenamic acid—ALOX5—lung—hematologic cancer	0.000963	0.0334	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—NFKBIA—hematologic cancer	0.00096	0.21	CrCbGaD
Meclofenamic acid—ALOX5—testis—hematologic cancer	0.000908	0.0316	CbGeAlD
Meclofenamic acid—SLCO1C1—lymph node—hematologic cancer	0.000813	0.0282	CbGeAlD
Meclofenamic acid—AKR1C3—Podofilox—Teniposide—hematologic cancer	0.000795	0.235	CbGdCrCtD
Meclofenamic acid—AKR1C3—lymph node—hematologic cancer	0.000747	0.0259	CbGeAlD
Meclofenamic acid—PTGS1—hematopoietic system—hematologic cancer	0.000665	0.0231	CbGeAlD
Meclofenamic acid—ALOX5—lymph node—hematologic cancer	0.000658	0.0229	CbGeAlD
Meclofenamic acid—PTGS2—hematopoietic system—hematologic cancer	0.000636	0.0221	CbGeAlD
Meclofenamic acid—AKR1C3—Vincristine—Vinorelbine—hematologic cancer	0.000506	0.15	CbGdCrCtD
Meclofenamic acid—AKR1C3—Podofilox—Etoposide—hematologic cancer	0.000473	0.14	CbGdCrCtD
Meclofenamic acid—PTGS1—blood—hematologic cancer	0.000441	0.0153	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—TP53—hematologic cancer	0.000425	0.0931	CrCbGaD
Meclofenamic acid—PTGS2—blood—hematologic cancer	0.000421	0.0146	CbGeAlD
Meclofenamic acid—PTGS2—bone marrow—hematologic cancer	0.000408	0.0142	CbGeAlD
Meclofenamic acid—AKR1C3—Vinblastine—Vinorelbine—hematologic cancer	0.000407	0.12	CbGdCrCtD
Meclofenamic acid—AKR1C3—Vincristine—Vinblastine—hematologic cancer	0.000404	0.12	CbGdCrCtD
Meclofenamic acid—PTGS1—lung—hematologic cancer	0.000386	0.0134	CbGeAlD
Meclofenamic acid—PTGS2—lung—hematologic cancer	0.000369	0.0128	CbGeAlD
Meclofenamic acid—PTGS1—testis—hematologic cancer	0.000365	0.0127	CbGeAlD
Meclofenamic acid—AKR1C3—Vinblastine—Vincristine—hematologic cancer	0.000325	0.0962	CbGdCrCtD
Meclofenamic acid—PTGS1—lymph node—hematologic cancer	0.000264	0.00918	CbGeAlD
Meclofenamic acid—Diclofenac—ALOX5—hematologic cancer	0.000254	0.0556	CrCbGaD
Meclofenamic acid—PTGS2—lymph node—hematologic cancer	0.000253	0.00878	CbGeAlD
Meclofenamic acid—Diclofenac—UGT1A1—hematologic cancer	0.000223	0.0488	CrCbGaD
Meclofenamic acid—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	9.84e-05	0.0291	CbGdCrCtD
Meclofenamic acid—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	9.84e-05	0.0291	CbGdCrCtD
Meclofenamic acid—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	9.62e-05	0.0285	CbGdCrCtD
Meclofenamic acid—Acetylsalicylic acid—ALB—hematologic cancer	7.41e-05	0.0162	CrCbGaD
Meclofenamic acid—Acetylsalicylic acid—ABCB1—hematologic cancer	7.07e-05	0.0155	CrCbGaD
Meclofenamic acid—Paraesthesia—Cisplatin—hematologic cancer	6.48e-05	0.000393	CcSEcCtD
Meclofenamic acid—Eosinophilia—Epirubicin—hematologic cancer	6.45e-05	0.000391	CcSEcCtD
Meclofenamic acid—Abdominal pain—Vincristine—hematologic cancer	6.45e-05	0.000391	CcSEcCtD
Meclofenamic acid—Asthenia—Thalidomide—hematologic cancer	6.38e-05	0.000387	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Gemcitabine—hematologic cancer	6.38e-05	0.000387	CcSEcCtD
Meclofenamic acid—Nausea—Lenalidomide—hematologic cancer	6.37e-05	0.000386	CcSEcCtD
Meclofenamic acid—Urticaria—Mitoxantrone—hematologic cancer	6.31e-05	0.000383	CcSEcCtD
Meclofenamic acid—Anorexia—Etoposide—hematologic cancer	6.3e-05	0.000382	CcSEcCtD
Meclofenamic acid—Pruritus—Thalidomide—hematologic cancer	6.29e-05	0.000382	CcSEcCtD
Meclofenamic acid—Diarrhoea—Thiotepa—hematologic cancer	6.29e-05	0.000382	CcSEcCtD
Meclofenamic acid—Abdominal pain—Irinotecan—hematologic cancer	6.28e-05	0.000381	CcSEcCtD
Meclofenamic acid—Abdominal pain—Mitoxantrone—hematologic cancer	6.28e-05	0.000381	CcSEcCtD
Meclofenamic acid—Nausea—Hydroxyurea—hematologic cancer	6.28e-05	0.000381	CcSEcCtD
Meclofenamic acid—Vomiting—Bortezomib—hematologic cancer	6.27e-05	0.00038	CcSEcCtD
Meclofenamic acid—Decreased appetite—Cisplatin—hematologic cancer	6.27e-05	0.00038	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Cisplatin—hematologic cancer	6.23e-05	0.000377	CcSEcCtD
Meclofenamic acid—Vomiting—Bleomycin—hematologic cancer	6.22e-05	0.000377	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Betamethasone—hematologic cancer	6.18e-05	0.000375	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Dexamethasone—hematologic cancer	6.18e-05	0.000375	CcSEcCtD
Meclofenamic acid—Discomfort—Triamcinolone—hematologic cancer	6.18e-05	0.000374	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	6.15e-05	0.000373	CcSEcCtD
Meclofenamic acid—Asthenia—Carmustine—hematologic cancer	6.13e-05	0.000372	CcSEcCtD
Meclofenamic acid—Vomiting—Vinorelbine—hematologic cancer	6.12e-05	0.000371	CcSEcCtD
Meclofenamic acid—Salicylic acid—ALB—hematologic cancer	6.1e-05	0.0134	CrCbGaD
Meclofenamic acid—Renal failure—Methotrexate—hematologic cancer	6.1e-05	0.00037	CcSEcCtD
Meclofenamic acid—Neutropenia—Epirubicin—hematologic cancer	6.09e-05	0.000369	CcSEcCtD
Meclofenamic acid—Diarrhoea—Thalidomide—hematologic cancer	6.09e-05	0.000369	CcSEcCtD
Meclofenamic acid—Asthenia—Alitretinoin—hematologic cancer	6.07e-05	0.000368	CcSEcCtD
Meclofenamic acid—Stomatitis—Methotrexate—hematologic cancer	6.05e-05	0.000367	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Methotrexate—hematologic cancer	6.03e-05	0.000366	CcSEcCtD
Meclofenamic acid—Malaise—Dexamethasone—hematologic cancer	6.01e-05	0.000364	CcSEcCtD
Meclofenamic acid—Malaise—Betamethasone—hematologic cancer	6.01e-05	0.000364	CcSEcCtD
Meclofenamic acid—Asthenia—Ifosfamide—hematologic cancer	6e-05	0.000364	CcSEcCtD
Meclofenamic acid—Oedema—Triamcinolone—hematologic cancer	5.99e-05	0.000363	CcSEcCtD
Meclofenamic acid—Pruritus—Alitretinoin—hematologic cancer	5.99e-05	0.000363	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—hematologic cancer	5.97e-05	0.000362	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Cisplatin—hematologic cancer	5.94e-05	0.00036	CcSEcCtD
Meclofenamic acid—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	5.94e-05	0.0176	CbGdCrCtD
Meclofenamic acid—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	5.94e-05	0.0176	CbGdCrCtD
Meclofenamic acid—Paraesthesia—Etoposide—hematologic cancer	5.93e-05	0.00036	CcSEcCtD
Meclofenamic acid—Pruritus—Ifosfamide—hematologic cancer	5.92e-05	0.000359	CcSEcCtD
Meclofenamic acid—Insomnia—Prednisolone—hematologic cancer	5.89e-05	0.000357	CcSEcCtD
Meclofenamic acid—Alopecia—Prednisone—hematologic cancer	5.89e-05	0.000357	CcSEcCtD
Meclofenamic acid—Nausea—Bortezomib—hematologic cancer	5.86e-05	0.000355	CcSEcCtD
Meclofenamic acid—Asthenia—Vincristine—hematologic cancer	5.85e-05	0.000355	CcSEcCtD
Meclofenamic acid—Paraesthesia—Prednisolone—hematologic cancer	5.85e-05	0.000355	CcSEcCtD
Meclofenamic acid—Vomiting—Thiotepa—hematologic cancer	5.85e-05	0.000355	CcSEcCtD
Meclofenamic acid—Diarrhoea—Carmustine—hematologic cancer	5.85e-05	0.000354	CcSEcCtD
Meclofenamic acid—Salicylic acid—ABCB1—hematologic cancer	5.82e-05	0.0128	CrCbGaD
Meclofenamic acid—Nausea—Bleomycin—hematologic cancer	5.81e-05	0.000352	CcSEcCtD
Meclofenamic acid—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	5.8e-05	0.0172	CbGdCrCtD
Meclofenamic acid—Diarrhoea—Alitretinoin—hematologic cancer	5.79e-05	0.000351	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Methotrexate—hematologic cancer	5.79e-05	0.000351	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	5.76e-05	0.000349	CcSEcCtD
Meclofenamic acid—Decreased appetite—Etoposide—hematologic cancer	5.74e-05	0.000348	CcSEcCtD
Meclofenamic acid—Diarrhoea—Ifosfamide—hematologic cancer	5.72e-05	0.000347	CcSEcCtD
Meclofenamic acid—Nausea—Vinorelbine—hematologic cancer	5.72e-05	0.000347	CcSEcCtD
Meclofenamic acid—Renal failure—Epirubicin—hematologic cancer	5.71e-05	0.000346	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Etoposide—hematologic cancer	5.7e-05	0.000346	CcSEcCtD
Meclofenamic acid—Asthenia—Mitoxantrone—hematologic cancer	5.7e-05	0.000346	CcSEcCtD
Meclofenamic acid—Asthenia—Irinotecan—hematologic cancer	5.7e-05	0.000346	CcSEcCtD
Meclofenamic acid—Fatigue—Etoposide—hematologic cancer	5.7e-05	0.000345	CcSEcCtD
Meclofenamic acid—Stomatitis—Epirubicin—hematologic cancer	5.66e-05	0.000343	CcSEcCtD
Meclofenamic acid—Vomiting—Thalidomide—hematologic cancer	5.66e-05	0.000343	CcSEcCtD
Meclofenamic acid—Constipation—Etoposide—hematologic cancer	5.65e-05	0.000343	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Epirubicin—hematologic cancer	5.64e-05	0.000342	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—hematologic cancer	5.63e-05	0.000342	CcSEcCtD
Meclofenamic acid—Discomfort—Betamethasone—hematologic cancer	5.6e-05	0.00034	CcSEcCtD
Meclofenamic acid—Discomfort—Dexamethasone—hematologic cancer	5.6e-05	0.00034	CcSEcCtD
Meclofenamic acid—Haemoglobin—Methotrexate—hematologic cancer	5.6e-05	0.000339	CcSEcCtD
Meclofenamic acid—Diarrhoea—Vincristine—hematologic cancer	5.58e-05	0.000338	CcSEcCtD
Meclofenamic acid—Haemorrhage—Methotrexate—hematologic cancer	5.57e-05	0.000338	CcSEcCtD
Meclofenamic acid—Asthenia—Gemcitabine—hematologic cancer	5.55e-05	0.000337	CcSEcCtD
Meclofenamic acid—Pruritus—Gemcitabine—hematologic cancer	5.47e-05	0.000332	CcSEcCtD
Meclofenamic acid—Vision blurred—Prednisone—hematologic cancer	5.47e-05	0.000332	CcSEcCtD
Meclofenamic acid—Nausea—Thiotepa—hematologic cancer	5.46e-05	0.000331	CcSEcCtD
Meclofenamic acid—Diclofenac—ALB—hematologic cancer	5.46e-05	0.012	CrCbGaD
Meclofenamic acid—Feeling abnormal—Etoposide—hematologic cancer	5.44e-05	0.00033	CcSEcCtD
Meclofenamic acid—Oedema—Dexamethasone—hematologic cancer	5.44e-05	0.00033	CcSEcCtD
Meclofenamic acid—Oedema—Betamethasone—hematologic cancer	5.44e-05	0.00033	CcSEcCtD
Meclofenamic acid—Diarrhoea—Mitoxantrone—hematologic cancer	5.43e-05	0.000329	CcSEcCtD
Meclofenamic acid—Diarrhoea—Irinotecan—hematologic cancer	5.43e-05	0.000329	CcSEcCtD
Meclofenamic acid—Vomiting—Carmustine—hematologic cancer	5.43e-05	0.000329	CcSEcCtD
Meclofenamic acid—Insomnia—Triamcinolone—hematologic cancer	5.42e-05	0.000329	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Epirubicin—hematologic cancer	5.42e-05	0.000329	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Etoposide—hematologic cancer	5.4e-05	0.000328	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Prednisone—hematologic cancer	5.38e-05	0.000326	CcSEcCtD
Meclofenamic acid—Vomiting—Alitretinoin—hematologic cancer	5.38e-05	0.000326	CcSEcCtD
Meclofenamic acid—Paraesthesia—Triamcinolone—hematologic cancer	5.38e-05	0.000326	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Prednisolone—hematologic cancer	5.37e-05	0.000326	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	5.33e-05	0.000323	CcSEcCtD
Meclofenamic acid—Vomiting—Ifosfamide—hematologic cancer	5.32e-05	0.000322	CcSEcCtD
Meclofenamic acid—Diarrhoea—Gemcitabine—hematologic cancer	5.29e-05	0.000321	CcSEcCtD
Meclofenamic acid—Nausea—Thalidomide—hematologic cancer	5.28e-05	0.00032	CcSEcCtD
Meclofenamic acid—Renal failure—Doxorubicin—hematologic cancer	5.28e-05	0.00032	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Methotrexate—hematologic cancer	5.27e-05	0.000319	CcSEcCtD
Meclofenamic acid—Urticaria—Etoposide—hematologic cancer	5.25e-05	0.000318	CcSEcCtD
Meclofenamic acid—Haemoglobin—Epirubicin—hematologic cancer	5.24e-05	0.000318	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—hematologic cancer	5.24e-05	0.000318	CcSEcCtD
Meclofenamic acid—Malaise—Prednisone—hematologic cancer	5.23e-05	0.000317	CcSEcCtD
Meclofenamic acid—Abdominal pain—Etoposide—hematologic cancer	5.22e-05	0.000317	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—hematologic cancer	5.22e-05	0.000317	CcSEcCtD
Meclofenamic acid—Haemorrhage—Epirubicin—hematologic cancer	5.21e-05	0.000316	CcSEcCtD
Meclofenamic acid—Diclofenac—ABCB1—hematologic cancer	5.21e-05	0.0114	CrCbGaD
Meclofenamic acid—Tinnitus—Methotrexate—hematologic cancer	5.19e-05	0.000315	CcSEcCtD
Meclofenamic acid—Vomiting—Vincristine—hematologic cancer	5.19e-05	0.000314	CcSEcCtD
Meclofenamic acid—Anorexia—Dexamethasone—hematologic cancer	5.18e-05	0.000314	CcSEcCtD
Meclofenamic acid—Anorexia—Betamethasone—hematologic cancer	5.18e-05	0.000314	CcSEcCtD
Meclofenamic acid—Urticaria—Prednisolone—hematologic cancer	5.18e-05	0.000314	CcSEcCtD
Meclofenamic acid—Asthenia—Cisplatin—hematologic cancer	5.17e-05	0.000314	CcSEcCtD
Meclofenamic acid—Fatigue—Triamcinolone—hematologic cancer	5.17e-05	0.000313	CcSEcCtD
Meclofenamic acid—Nausea—Carmustine—hematologic cancer	5.07e-05	0.000308	CcSEcCtD
Meclofenamic acid—Vomiting—Mitoxantrone—hematologic cancer	5.05e-05	0.000306	CcSEcCtD
Meclofenamic acid—Vomiting—Irinotecan—hematologic cancer	5.05e-05	0.000306	CcSEcCtD
Meclofenamic acid—Nausea—Alitretinoin—hematologic cancer	5.03e-05	0.000305	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Doxorubicin—hematologic cancer	5.01e-05	0.000304	CcSEcCtD
Meclofenamic acid—Nausea—Ifosfamide—hematologic cancer	4.97e-05	0.000301	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Triamcinolone—hematologic cancer	4.94e-05	0.000299	CcSEcCtD
Meclofenamic acid—Diarrhoea—Cisplatin—hematologic cancer	4.93e-05	0.000299	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Epirubicin—hematologic cancer	4.93e-05	0.000299	CcSEcCtD
Meclofenamic acid—Alopecia—Methotrexate—hematologic cancer	4.92e-05	0.000298	CcSEcCtD
Meclofenamic acid—Vomiting—Gemcitabine—hematologic cancer	4.92e-05	0.000298	CcSEcCtD
Meclofenamic acid—Insomnia—Betamethasone—hematologic cancer	4.92e-05	0.000298	CcSEcCtD
Meclofenamic acid—Insomnia—Dexamethasone—hematologic cancer	4.92e-05	0.000298	CcSEcCtD
Meclofenamic acid—Paraesthesia—Betamethasone—hematologic cancer	4.88e-05	0.000296	CcSEcCtD
Meclofenamic acid—Paraesthesia—Dexamethasone—hematologic cancer	4.88e-05	0.000296	CcSEcCtD
Meclofenamic acid—Discomfort—Prednisone—hematologic cancer	4.88e-05	0.000296	CcSEcCtD
Meclofenamic acid—Tinnitus—Epirubicin—hematologic cancer	4.86e-05	0.000295	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—hematologic cancer	4.85e-05	0.000294	CcSEcCtD
Meclofenamic acid—Nausea—Vincristine—hematologic cancer	4.84e-05	0.000294	CcSEcCtD
Meclofenamic acid—Haemorrhage—Doxorubicin—hematologic cancer	4.82e-05	0.000292	CcSEcCtD
Meclofenamic acid—Urticaria—Triamcinolone—hematologic cancer	4.76e-05	0.000289	CcSEcCtD
Meclofenamic acid—Asthenia—Etoposide—hematologic cancer	4.74e-05	0.000287	CcSEcCtD
Meclofenamic acid—Oedema—Prednisone—hematologic cancer	4.73e-05	0.000287	CcSEcCtD
Meclofenamic acid—Decreased appetite—Dexamethasone—hematologic cancer	4.73e-05	0.000287	CcSEcCtD
Meclofenamic acid—Decreased appetite—Betamethasone—hematologic cancer	4.73e-05	0.000287	CcSEcCtD
Meclofenamic acid—Nausea—Mitoxantrone—hematologic cancer	4.72e-05	0.000286	CcSEcCtD
Meclofenamic acid—Nausea—Irinotecan—hematologic cancer	4.72e-05	0.000286	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.69e-05	0.000285	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.69e-05	0.000285	CcSEcCtD
Meclofenamic acid—Fatigue—Dexamethasone—hematologic cancer	4.69e-05	0.000284	CcSEcCtD
Meclofenamic acid—Fatigue—Betamethasone—hematologic cancer	4.69e-05	0.000284	CcSEcCtD
Meclofenamic acid—Pruritus—Etoposide—hematologic cancer	4.67e-05	0.000283	CcSEcCtD
Meclofenamic acid—Alopecia—Epirubicin—hematologic cancer	4.61e-05	0.000279	CcSEcCtD
Meclofenamic acid—Nausea—Gemcitabine—hematologic cancer	4.6e-05	0.000279	CcSEcCtD
Meclofenamic acid—Vomiting—Cisplatin—hematologic cancer	4.58e-05	0.000278	CcSEcCtD
Meclofenamic acid—Vision blurred—Methotrexate—hematologic cancer	4.57e-05	0.000277	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Doxorubicin—hematologic cancer	4.56e-05	0.000276	CcSEcCtD
Meclofenamic acid—Diarrhoea—Etoposide—hematologic cancer	4.52e-05	0.000274	CcSEcCtD
Meclofenamic acid—Anorexia—Prednisone—hematologic cancer	4.51e-05	0.000274	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Methotrexate—hematologic cancer	4.5e-05	0.000273	CcSEcCtD
Meclofenamic acid—Tinnitus—Doxorubicin—hematologic cancer	4.5e-05	0.000273	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Betamethasone—hematologic cancer	4.48e-05	0.000272	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Dexamethasone—hematologic cancer	4.48e-05	0.000272	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Betamethasone—hematologic cancer	4.45e-05	0.00027	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.45e-05	0.00027	CcSEcCtD
Meclofenamic acid—Malaise—Methotrexate—hematologic cancer	4.37e-05	0.000265	CcSEcCtD
Meclofenamic acid—Leukopenia—Methotrexate—hematologic cancer	4.34e-05	0.000263	CcSEcCtD
Meclofenamic acid—Urticaria—Betamethasone—hematologic cancer	4.32e-05	0.000262	CcSEcCtD
Meclofenamic acid—Urticaria—Dexamethasone—hematologic cancer	4.32e-05	0.000262	CcSEcCtD
Meclofenamic acid—Asthenia—Triamcinolone—hematologic cancer	4.3e-05	0.000261	CcSEcCtD
Meclofenamic acid—Abdominal pain—Dexamethasone—hematologic cancer	4.3e-05	0.000261	CcSEcCtD
Meclofenamic acid—Abdominal pain—Betamethasone—hematologic cancer	4.3e-05	0.000261	CcSEcCtD
Meclofenamic acid—Nausea—Cisplatin—hematologic cancer	4.28e-05	0.00026	CcSEcCtD
Meclofenamic acid—Insomnia—Prednisone—hematologic cancer	4.28e-05	0.00026	CcSEcCtD
Meclofenamic acid—Vision blurred—Epirubicin—hematologic cancer	4.28e-05	0.000259	CcSEcCtD
Meclofenamic acid—Alopecia—Doxorubicin—hematologic cancer	4.26e-05	0.000258	CcSEcCtD
Meclofenamic acid—Paraesthesia—Prednisone—hematologic cancer	4.25e-05	0.000258	CcSEcCtD
Meclofenamic acid—Pruritus—Triamcinolone—hematologic cancer	4.24e-05	0.000257	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Epirubicin—hematologic cancer	4.21e-05	0.000255	CcSEcCtD
Meclofenamic acid—Vomiting—Etoposide—hematologic cancer	4.2e-05	0.000255	CcSEcCtD
Meclofenamic acid—Decreased appetite—Prednisone—hematologic cancer	4.12e-05	0.00025	CcSEcCtD
Meclofenamic acid—Malaise—Epirubicin—hematologic cancer	4.09e-05	0.000248	CcSEcCtD
Meclofenamic acid—Fatigue—Prednisone—hematologic cancer	4.08e-05	0.000248	CcSEcCtD
Meclofenamic acid—Discomfort—Methotrexate—hematologic cancer	4.08e-05	0.000247	CcSEcCtD
Meclofenamic acid—Leukopenia—Epirubicin—hematologic cancer	4.06e-05	0.000246	CcSEcCtD
Meclofenamic acid—Constipation—Prednisone—hematologic cancer	4.05e-05	0.000246	CcSEcCtD
Meclofenamic acid—Palpitations—Epirubicin—hematologic cancer	4.01e-05	0.000243	CcSEcCtD
Meclofenamic acid—Vision blurred—Doxorubicin—hematologic cancer	3.96e-05	0.00024	CcSEcCtD
Meclofenamic acid—Nausea—Etoposide—hematologic cancer	3.92e-05	0.000238	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Prednisone—hematologic cancer	3.9e-05	0.000237	CcSEcCtD
Meclofenamic acid—Asthenia—Dexamethasone—hematologic cancer	3.9e-05	0.000237	CcSEcCtD
Meclofenamic acid—Asthenia—Betamethasone—hematologic cancer	3.9e-05	0.000237	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—hematologic cancer	3.9e-05	0.000236	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Prednisone—hematologic cancer	3.87e-05	0.000235	CcSEcCtD
Meclofenamic acid—Nausea—Prednisolone—hematologic cancer	3.87e-05	0.000235	CcSEcCtD
Meclofenamic acid—Pruritus—Dexamethasone—hematologic cancer	3.85e-05	0.000233	CcSEcCtD
Meclofenamic acid—Pruritus—Betamethasone—hematologic cancer	3.85e-05	0.000233	CcSEcCtD
Meclofenamic acid—Discomfort—Epirubicin—hematologic cancer	3.82e-05	0.000231	CcSEcCtD
Meclofenamic acid—Vomiting—Triamcinolone—hematologic cancer	3.81e-05	0.000231	CcSEcCtD
Meclofenamic acid—Malaise—Doxorubicin—hematologic cancer	3.79e-05	0.00023	CcSEcCtD
Meclofenamic acid—Anorexia—Methotrexate—hematologic cancer	3.77e-05	0.000229	CcSEcCtD
Meclofenamic acid—Urticaria—Prednisone—hematologic cancer	3.76e-05	0.000228	CcSEcCtD
Meclofenamic acid—Leukopenia—Doxorubicin—hematologic cancer	3.76e-05	0.000228	CcSEcCtD
Meclofenamic acid—Abdominal pain—Prednisone—hematologic cancer	3.74e-05	0.000227	CcSEcCtD
Meclofenamic acid—Diarrhoea—Dexamethasone—hematologic cancer	3.72e-05	0.000226	CcSEcCtD
Meclofenamic acid—Diarrhoea—Betamethasone—hematologic cancer	3.72e-05	0.000226	CcSEcCtD
Meclofenamic acid—Palpitations—Doxorubicin—hematologic cancer	3.71e-05	0.000225	CcSEcCtD
Meclofenamic acid—Oedema—Epirubicin—hematologic cancer	3.7e-05	0.000225	CcSEcCtD
Meclofenamic acid—Insomnia—Methotrexate—hematologic cancer	3.58e-05	0.000217	CcSEcCtD
Meclofenamic acid—Nausea—Triamcinolone—hematologic cancer	3.56e-05	0.000216	CcSEcCtD
Meclofenamic acid—Paraesthesia—Methotrexate—hematologic cancer	3.55e-05	0.000215	CcSEcCtD
Meclofenamic acid—Discomfort—Doxorubicin—hematologic cancer	3.53e-05	0.000214	CcSEcCtD
Meclofenamic acid—Anorexia—Epirubicin—hematologic cancer	3.53e-05	0.000214	CcSEcCtD
Meclofenamic acid—Vomiting—Dexamethasone—hematologic cancer	3.46e-05	0.00021	CcSEcCtD
Meclofenamic acid—Vomiting—Betamethasone—hematologic cancer	3.46e-05	0.00021	CcSEcCtD
Meclofenamic acid—Decreased appetite—Methotrexate—hematologic cancer	3.44e-05	0.000209	CcSEcCtD
Meclofenamic acid—Oedema—Doxorubicin—hematologic cancer	3.43e-05	0.000208	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.42e-05	0.000207	CcSEcCtD
Meclofenamic acid—Fatigue—Methotrexate—hematologic cancer	3.41e-05	0.000207	CcSEcCtD
Meclofenamic acid—Asthenia—Prednisone—hematologic cancer	3.4e-05	0.000206	CcSEcCtD
Meclofenamic acid—Pruritus—Prednisone—hematologic cancer	3.35e-05	0.000203	CcSEcCtD
Meclofenamic acid—Insomnia—Epirubicin—hematologic cancer	3.35e-05	0.000203	CcSEcCtD
Meclofenamic acid—Paraesthesia—Epirubicin—hematologic cancer	3.33e-05	0.000202	CcSEcCtD
Meclofenamic acid—Anorexia—Doxorubicin—hematologic cancer	3.27e-05	0.000198	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Methotrexate—hematologic cancer	3.26e-05	0.000198	CcSEcCtD
Meclofenamic acid—Diarrhoea—Prednisone—hematologic cancer	3.24e-05	0.000196	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Methotrexate—hematologic cancer	3.24e-05	0.000196	CcSEcCtD
Meclofenamic acid—Nausea—Betamethasone—hematologic cancer	3.23e-05	0.000196	CcSEcCtD
Meclofenamic acid—Nausea—Dexamethasone—hematologic cancer	3.23e-05	0.000196	CcSEcCtD
Meclofenamic acid—Decreased appetite—Epirubicin—hematologic cancer	3.22e-05	0.000195	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.2e-05	0.000194	CcSEcCtD
Meclofenamic acid—Fatigue—Epirubicin—hematologic cancer	3.19e-05	0.000194	CcSEcCtD
Meclofenamic acid—Constipation—Epirubicin—hematologic cancer	3.17e-05	0.000192	CcSEcCtD
Meclofenamic acid—Urticaria—Methotrexate—hematologic cancer	3.14e-05	0.000191	CcSEcCtD
Meclofenamic acid—Abdominal pain—Methotrexate—hematologic cancer	3.13e-05	0.00019	CcSEcCtD
Meclofenamic acid—Insomnia—Doxorubicin—hematologic cancer	3.1e-05	0.000188	CcSEcCtD
Meclofenamic acid—Paraesthesia—Doxorubicin—hematologic cancer	3.08e-05	0.000187	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Epirubicin—hematologic cancer	3.05e-05	0.000185	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Epirubicin—hematologic cancer	3.03e-05	0.000184	CcSEcCtD
Meclofenamic acid—Vomiting—Prednisone—hematologic cancer	3.01e-05	0.000183	CcSEcCtD
Meclofenamic acid—Decreased appetite—Doxorubicin—hematologic cancer	2.98e-05	0.000181	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.96e-05	0.000179	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—hematologic cancer	2.95e-05	0.000179	CcSEcCtD
Meclofenamic acid—Urticaria—Epirubicin—hematologic cancer	2.94e-05	0.000178	CcSEcCtD
Meclofenamic acid—Constipation—Doxorubicin—hematologic cancer	2.93e-05	0.000178	CcSEcCtD
Meclofenamic acid—Abdominal pain—Epirubicin—hematologic cancer	2.93e-05	0.000177	CcSEcCtD
Meclofenamic acid—Asthenia—Methotrexate—hematologic cancer	2.84e-05	0.000172	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Doxorubicin—hematologic cancer	2.82e-05	0.000171	CcSEcCtD
Meclofenamic acid—Nausea—Prednisone—hematologic cancer	2.81e-05	0.000171	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.8e-05	0.00017	CcSEcCtD
Meclofenamic acid—Pruritus—Methotrexate—hematologic cancer	2.8e-05	0.00017	CcSEcCtD
Meclofenamic acid—Urticaria—Doxorubicin—hematologic cancer	2.72e-05	0.000165	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—hematologic cancer	2.71e-05	0.000164	CcSEcCtD
Meclofenamic acid—Diarrhoea—Methotrexate—hematologic cancer	2.71e-05	0.000164	CcSEcCtD
Meclofenamic acid—Asthenia—Epirubicin—hematologic cancer	2.66e-05	0.000161	CcSEcCtD
Meclofenamic acid—Pruritus—Epirubicin—hematologic cancer	2.62e-05	0.000159	CcSEcCtD
Meclofenamic acid—Diarrhoea—Epirubicin—hematologic cancer	2.53e-05	0.000154	CcSEcCtD
Meclofenamic acid—Vomiting—Methotrexate—hematologic cancer	2.52e-05	0.000153	CcSEcCtD
Meclofenamic acid—Asthenia—Doxorubicin—hematologic cancer	2.46e-05	0.000149	CcSEcCtD
Meclofenamic acid—Pruritus—Doxorubicin—hematologic cancer	2.42e-05	0.000147	CcSEcCtD
Meclofenamic acid—Vomiting—Epirubicin—hematologic cancer	2.35e-05	0.000143	CcSEcCtD
Meclofenamic acid—Nausea—Methotrexate—hematologic cancer	2.35e-05	0.000143	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—hematologic cancer	2.34e-05	0.000142	CcSEcCtD
Meclofenamic acid—Nausea—Epirubicin—hematologic cancer	2.2e-05	0.000133	CcSEcCtD
Meclofenamic acid—Vomiting—Doxorubicin—hematologic cancer	2.18e-05	0.000132	CcSEcCtD
Meclofenamic acid—Nausea—Doxorubicin—hematologic cancer	2.04e-05	0.000123	CcSEcCtD
Meclofenamic acid—AKR1C3—Signaling Pathways—TERT—hematologic cancer	9.74e-06	0.000144	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3R1—hematologic cancer	9.73e-06	0.000144	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NUP214—hematologic cancer	9.7e-06	0.000143	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RPS14—hematologic cancer	9.69e-06	0.000143	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—DKK1—hematologic cancer	9.61e-06	0.000142	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.6e-06	0.000142	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT5B—hematologic cancer	9.54e-06	0.000141	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NUP98—hematologic cancer	9.54e-06	0.000141	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PDGFB—hematologic cancer	9.51e-06	0.00014	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ABCG2—hematologic cancer	9.5e-06	0.00014	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTR—hematologic cancer	9.5e-06	0.00014	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—JAK2—hematologic cancer	9.46e-06	0.00014	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—IDH1—hematologic cancer	9.36e-06	0.000138	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	9.35e-06	0.000138	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CST3—hematologic cancer	9.32e-06	0.000138	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ENO2—hematologic cancer	9.32e-06	0.000138	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TSC2—hematologic cancer	9.3e-06	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	9.28e-06	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ADCY7—hematologic cancer	9.26e-06	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TXN—hematologic cancer	9.25e-06	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ABCC3—hematologic cancer	9.25e-06	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTO1—hematologic cancer	9.25e-06	0.000137	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MDM2—hematologic cancer	9.23e-06	0.000136	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NUP214—hematologic cancer	9.19e-06	0.000136	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CREBBP—hematologic cancer	9.14e-06	0.000135	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CREBBP—hematologic cancer	9.1e-06	0.000134	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SPHK1—hematologic cancer	9.05e-06	0.000134	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTT1—hematologic cancer	9.04e-06	0.000133	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—XIAP—hematologic cancer	9.01e-06	0.000133	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTR—hematologic cancer	9.01e-06	0.000133	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CB—hematologic cancer	8.98e-06	0.000133	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MTOR—hematologic cancer	8.98e-06	0.000133	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CD4—hematologic cancer	8.97e-06	0.000132	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FGFR3—hematologic cancer	8.94e-06	0.000132	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.9e-06	0.000131	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK14—hematologic cancer	8.85e-06	0.000131	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SDC1—hematologic cancer	8.83e-06	0.00013	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ENO2—hematologic cancer	8.83e-06	0.00013	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SMARCA4—hematologic cancer	8.78e-06	0.00013	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—UGT1A1—hematologic cancer	8.7e-06	0.000128	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ESR1—hematologic cancer	8.69e-06	0.000128	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CD—hematologic cancer	8.66e-06	0.000128	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CD—hematologic cancer	8.63e-06	0.000127	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FN1—hematologic cancer	8.58e-06	0.000127	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ALB—hematologic cancer	8.55e-06	0.000126	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.52e-06	0.000126	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ALB—hematologic cancer	8.52e-06	0.000126	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—BAD—hematologic cancer	8.48e-06	0.000125	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NFKBIA—hematologic cancer	8.48e-06	0.000125	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CRABP1—hematologic cancer	8.46e-06	0.000125	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC22A1—hematologic cancer	8.46e-06	0.000125	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.44e-06	0.000125	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1B—hematologic cancer	8.43e-06	0.000124	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NOTCH1—hematologic cancer	8.4e-06	0.000124	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SDC1—hematologic cancer	8.37e-06	0.000124	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.33e-06	0.000123	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALOX5—hematologic cancer	8.25e-06	0.000122	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	8.24e-06	0.000122	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CD80—hematologic cancer	8.23e-06	0.000121	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CG—hematologic cancer	8.21e-06	0.000121	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KIT—hematologic cancer	8.21e-06	0.000121	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3R1—hematologic cancer	8.18e-06	0.000121	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3R1—hematologic cancer	8.15e-06	0.00012	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—LCK—hematologic cancer	8.11e-06	0.00012	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTPN11—hematologic cancer	8.07e-06	0.000119	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NUP98—hematologic cancer	7.99e-06	0.000118	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.97e-06	0.000118	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—H3F3A—hematologic cancer	7.95e-06	0.000117	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CREB1—hematologic cancer	7.82e-06	0.000115	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1A—hematologic cancer	7.78e-06	0.000115	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTEN—hematologic cancer	7.76e-06	0.000115	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ADCY7—hematologic cancer	7.75e-06	0.000114	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOA3—hematologic cancer	7.75e-06	0.000114	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRKCZ—hematologic cancer	7.73e-06	0.000114	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—BRAF—hematologic cancer	7.72e-06	0.000114	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NUP214—hematologic cancer	7.7e-06	0.000114	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCL2—hematologic cancer	7.65e-06	0.000113	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6R—hematologic cancer	7.62e-06	0.000113	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.62e-06	0.000113	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CREBBP—hematologic cancer	7.61e-06	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CALR—hematologic cancer	7.59e-06	0.000112	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CB—hematologic cancer	7.55e-06	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ABCG2—hematologic cancer	7.54e-06	0.000111	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTR—hematologic cancer	7.54e-06	0.000111	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CB—hematologic cancer	7.52e-06	0.000111	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NQO1—hematologic cancer	7.51e-06	0.000111	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CD44—hematologic cancer	7.51e-06	0.000111	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PARP1—hematologic cancer	7.46e-06	0.00011	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EP300—hematologic cancer	7.4e-06	0.000109	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ENO2—hematologic cancer	7.4e-06	0.000109	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.35e-06	0.000109	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FBXW7—hematologic cancer	7.34e-06	0.000108	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAP2K1—hematologic cancer	7.27e-06	0.000107	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CD—hematologic cancer	7.22e-06	0.000107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CXCR4—hematologic cancer	7.2e-06	0.000106	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HDAC2—hematologic cancer	7.2e-06	0.000106	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SRC—hematologic cancer	7.2e-06	0.000106	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTT1—hematologic cancer	7.17e-06	0.000106	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CD44—hematologic cancer	7.12e-06	0.000105	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYCS—hematologic cancer	7.11e-06	0.000105	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.06e-06	0.000104	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HSP90AA1—hematologic cancer	7.06e-06	0.000104	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CBL—hematologic cancer	7.02e-06	0.000104	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SDC1—hematologic cancer	7.01e-06	0.000104	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.96e-06	0.000103	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—STAT3—hematologic cancer	6.94e-06	0.000103	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NRAS—hematologic cancer	6.93e-06	0.000102	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FGF2—hematologic cancer	6.91e-06	0.000102	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3R1—hematologic cancer	6.82e-06	0.000101	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.7e-06	9.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HSP90AA1—hematologic cancer	6.69e-06	9.88e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MAPK3—hematologic cancer	6.63e-06	9.79e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JAK2—hematologic cancer	6.62e-06	9.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.61e-06	9.76e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTEN—hematologic cancer	6.53e-06	9.64e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTEN—hematologic cancer	6.5e-06	9.6e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MDM2—hematologic cancer	6.47e-06	9.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT1—hematologic cancer	6.45e-06	9.53e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MYC—hematologic cancer	6.45e-06	9.53e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TGFB1—hematologic cancer	6.44e-06	9.5e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.35e-06	9.38e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.32e-06	9.34e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MTOR—hematologic cancer	6.29e-06	9.29e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CB—hematologic cancer	6.29e-06	9.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTP1—hematologic cancer	6.26e-06	9.25e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—EP300—hematologic cancer	6.22e-06	9.19e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—EP300—hematologic cancer	6.2e-06	9.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.06e-06	8.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GRB2—hematologic cancer	6.04e-06	8.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PDGFA—hematologic cancer	6.02e-06	8.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NQO1—hematologic cancer	5.96e-06	8.8e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CD44—hematologic cancer	5.96e-06	8.8e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—hematologic cancer	5.96e-06	8.8e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KITLG—hematologic cancer	5.94e-06	8.77e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ABCB1—hematologic cancer	5.93e-06	8.76e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1B—hematologic cancer	5.9e-06	8.72e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.84e-06	8.62e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT5A—hematologic cancer	5.8e-06	8.57e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CASP3—hematologic cancer	5.79e-06	8.54e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL2—hematologic cancer	5.78e-06	8.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NCOR1—hematologic cancer	5.76e-06	8.5e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTM1—hematologic cancer	5.76e-06	8.5e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN2B—hematologic cancer	5.75e-06	8.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYCS—hematologic cancer	5.64e-06	8.33e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCND1—hematologic cancer	5.63e-06	8.32e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JUN—hematologic cancer	5.62e-06	8.3e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HSP90AA1—hematologic cancer	5.61e-06	8.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CD86—hematologic cancer	5.56e-06	8.22e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HES1—hematologic cancer	5.49e-06	8.1e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CA—hematologic cancer	5.48e-06	8.09e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NCOR1—hematologic cancer	5.46e-06	8.06e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1A—hematologic cancer	5.45e-06	8.05e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTEN—hematologic cancer	5.44e-06	8.03e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGF1—hematologic cancer	5.39e-06	7.97e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK8—hematologic cancer	5.32e-06	7.85e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FOXO1—hematologic cancer	5.32e-06	7.85e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PDGFRB—hematologic cancer	5.31e-06	7.84e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PDGFRA—hematologic cancer	5.22e-06	7.72e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRKCG—hematologic cancer	5.21e-06	7.69e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—JAK1—hematologic cancer	5.21e-06	7.69e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EP300—hematologic cancer	5.18e-06	7.66e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTHFR—hematologic cancer	5.09e-06	7.51e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—hematologic cancer	5.07e-06	7.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.04e-06	7.45e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SRC—hematologic cancer	5.04e-06	7.44e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTP1—hematologic cancer	4.97e-06	7.34e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—VEGFA—hematologic cancer	4.91e-06	7.25e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—STAT3—hematologic cancer	4.86e-06	7.18e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NRAS—hematologic cancer	4.85e-06	7.16e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—hematologic cancer	4.85e-06	7.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTHFR—hematologic cancer	4.82e-06	7.12e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.81e-06	7.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HLA-A—hematologic cancer	4.81e-06	7.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TERT—hematologic cancer	4.81e-06	7.1e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ABCB1—hematologic cancer	4.71e-06	6.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PDGFB—hematologic cancer	4.69e-06	6.93e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK3—hematologic cancer	4.64e-06	6.86e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CA—hematologic cancer	4.6e-06	6.8e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TSC2—hematologic cancer	4.59e-06	6.77e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CA—hematologic cancer	4.59e-06	6.77e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOR1—hematologic cancer	4.57e-06	6.75e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTM1—hematologic cancer	4.57e-06	6.75e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MYC—hematologic cancer	4.52e-06	6.67e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TGFB1—hematologic cancer	4.51e-06	6.66e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.48e-06	6.62e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT1—hematologic cancer	4.47e-06	6.61e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGFR3—hematologic cancer	4.41e-06	6.52e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CG—hematologic cancer	4.27e-06	6.31e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BAD—hematologic cancer	4.18e-06	6.18e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—hematologic cancer	4.17e-06	6.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOTCH1—hematologic cancer	4.14e-06	6.12e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CD80—hematologic cancer	4.06e-06	5.99e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KIT—hematologic cancer	4.05e-06	5.98e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTHFR—hematologic cancer	4.04e-06	5.96e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTPN11—hematologic cancer	3.98e-06	5.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CREBBP—hematologic cancer	3.96e-06	5.85e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CREB1—hematologic cancer	3.86e-06	5.69e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CA—hematologic cancer	3.84e-06	5.66e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BRAF—hematologic cancer	3.81e-06	5.62e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6R—hematologic cancer	3.76e-06	5.56e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKT1—hematologic cancer	3.76e-06	5.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.76e-06	5.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CREBBP—hematologic cancer	3.76e-06	5.55e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKT1—hematologic cancer	3.75e-06	5.53e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—hematologic cancer	3.71e-06	5.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALB—hematologic cancer	3.71e-06	5.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MAP2K1—hematologic cancer	3.59e-06	5.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CD—hematologic cancer	3.56e-06	5.26e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.56e-06	5.26e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—hematologic cancer	3.55e-06	5.24e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.55e-06	5.24e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGF2—hematologic cancer	3.41e-06	5.04e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—hematologic cancer	3.4e-06	5.01e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CG—hematologic cancer	3.39e-06	5.01e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3R1—hematologic cancer	3.36e-06	4.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.27e-06	4.84e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—JAK2—hematologic cancer	3.27e-06	4.83e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MDM2—hematologic cancer	3.19e-06	4.71e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CREBBP—hematologic cancer	3.15e-06	4.65e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT1—hematologic cancer	3.13e-06	4.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTOR—hematologic cancer	3.1e-06	4.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CB—hematologic cancer	3.1e-06	4.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CD4—hematologic cancer	3.1e-06	4.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CD—hematologic cancer	2.98e-06	4.4e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALB—hematologic cancer	2.94e-06	4.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1B—hematologic cancer	2.91e-06	4.3e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTEN—hematologic cancer	2.83e-06	4.18e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.82e-06	4.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—EP300—hematologic cancer	2.7e-06	3.99e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1A—hematologic cancer	2.69e-06	3.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTEN—hematologic cancer	2.68e-06	3.96e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CB—hematologic cancer	2.6e-06	3.84e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EP300—hematologic cancer	2.56e-06	3.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SRC—hematologic cancer	2.49e-06	3.67e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT3—hematologic cancer	2.4e-06	3.54e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NRAS—hematologic cancer	2.39e-06	3.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MAPK3—hematologic cancer	2.29e-06	3.38e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTEN—hematologic cancer	2.25e-06	3.32e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MYC—hematologic cancer	2.23e-06	3.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFB1—hematologic cancer	2.22e-06	3.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—EP300—hematologic cancer	2.14e-06	3.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—hematologic cancer	2.06e-06	3.04e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CA—hematologic cancer	2e-06	2.95e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CA—hematologic cancer	1.89e-06	2.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—hematologic cancer	1.75e-06	2.59e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—hematologic cancer	1.68e-06	2.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKT1—hematologic cancer	1.63e-06	2.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.58e-06	2.34e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT1—hematologic cancer	1.55e-06	2.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKT1—hematologic cancer	1.29e-06	1.91e-05	CbGpPWpGaD
